Rationale and design of the randomized, double-blind trial testing INtraveNous and Oral administration of elinogrel, a selective and reversible P2Y12-receptor inhibitor, versus clopidogrel to eVAluate Tolerability and Efficacy in nonurgent Percutaneous Coronary Interventions patients (INNOVATE-PCI)

✍ Scribed by Sergio Leonardi; Sunil V. Rao; Robert A. Harrington; Deepak L. Bhatt; C. Michael Gibson; Matthew T. Roe; Janusz Kochman; Kurt Huber; Uwe Zeymer; Mina Madan; Daniel D. Gretler; Matthew W. McClure; Gayle E. Paynter; Vivian Thompson; Robert C. Welsh

• Book ID: 116192130
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 375 KB
• Volume: 160
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2010.04.008